DOCSLIB.ORG

Implementing Environment and Health Information System in Europe

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Implementing Environment and Health Information System in Europe WORLD HEALTH ORGANIZATION ORGANISATION MONDIALE DE LA SANTÉ REGIONAL OFFICE FOR EUROPE BUREAU RÉGIONAL DE L'EUROPE WELTGESUNDHEITSORGANISATION ВСЕМИРНАЯ ОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯ REGIONALBÜRO FÜR EUROPA ЕВРОПЕЙСКОЕ РЕГИОНАЛЬНОЕ БЮРО EUROPEAN CENTRE FOR ENVIRONMENT AND HEALTH BONN OFFICE IMPLEMENTING ENVIRONMENT AND HEALTH INFORMATION SYSTEM IN EUROPE ENHIS Grant Agreement SPC 2003112 between the European Commission, DG Sanco and World Health Organization, Regional Office for Europe FINAL TECHNICAL REPORT 1 JUNE 2004 – 31 OCTOBER 2005 WHO ECEH, Bonn, December 2005 The views expressed in this report can in no way be taken to reflect the official opinion of the European Community EU/05/5046032 ABSTRACT This report summarizes the results of the project ‘Implementing environment and health information system in Europe – ENHIS’ (co-sponsored by EC DG Sanco) imple- mented by WHO European Centre for Environment and Health and partner institutions from 11 Member States. The project has developed methodological and technical ele- ments of a comprehensive information system for monitoring and evaluating the envi- ronmental health risks and effects of interventions focusing on children’s health. Meth- odological guidelines for information generation, health impact assessments (HIA), pol- icy-oriented analysis and reporting and for a ‘core’ set of children’s environmental health indicators were developed and implemented on a pilot basis. A network of col- laborating centres was created to strengthening environment and health information capacities in Europe and to maintain the system relevance for the member states. The products comprise HIA of outdoor air and drinking water pollution, policy analysis and fact-sheets’ indicator-based reporting, and web site for dissemination of the information collected by the system. These results and developments will be further advanced in a second phase of the ENHIS-2 project (2005-20007). Keywords ENVIRONMENTAL HEALTH CHILDREN’S HEALTH INFORMATION SYSTEMS POLICY-MAKING EUROPE Address requests about publications of the WHO Regional Office to: • by e-mail [email protected] (for copies of publications) [email protected] (for permission to reproduce them) [email protected] (for permission to translate them) • by post Publications WHO Regional Office for Europe Scherfigsvej 8 DK-2100 Copenhagen Ø, Denmark © World Health Organization 2005 All rights reserved. The Regional Office for Europe of the World Health Organization welcomes requests for permission to reproduce or translate its publications, in part or in full. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Where the designation “country or area” appears in the headings of tables, it covers countries, territories, cities, or areas. Dot- ted lines on maps represent approximate borderlines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions accepted, the names of proprietary products are distinguished by initial capital letters. The World Health Organization does not warrant that the information contained in this publication is complete and correct and shall not be liable for any damages incurred as a result of its use. The views expressed by authors or editors do not necessarily represent the decisions or the stated policy of the World Health Organization. ENHIS Final Technical Report – December 2005 Table of Contents Table of Contents......................................................................................................................ii ENHIS partner organizations and project participants....................................................... v Executive summary .................................................................................................................ix List of Abbreviations..............................................................................................................xv Introduction .............................................................................................................................. 1 Chapter 1 Support to National Collaborating Centres......................................................... 4 1.1 Introduction and background........................................................................................... 4 1.2 Aim and Objectives........................................................................................................... 4 1.3 Methods ............................................................................................................................ 5 1.4 Results .............................................................................................................................. 5 1.5 Conclusion........................................................................................................................ 7 Constraints and lessons learnt ........................................................................................... 8 Follow-up in ENHIS-2........................................................................................................ 8 Chapter 2 Determine information needs of policies............................................................ 10 2.1 Introduction and background......................................................................................... 10 2.2 Aim and objectives..........................................................................................................10 2.3 Methods and instruments................................................................................................ 11 2.4 Results and Key Findings............................................................................................... 12 General question .............................................................................................................. 12 Air Quality........................................................................................................................ 14 Noise................................................................................................................................. 15 Housing ............................................................................................................................ 16 Traffic ............................................................................................................................... 17 Water and Sanitation........................................................................................................ 17 Radiation .......................................................................................................................... 18 2.5. Conclusion..................................................................................................................... 18 Constraints and lessons learnt ......................................................................................... 19 Follow-up in ENHIS-2...................................................................................................... 20 Chapter 3 Update core set of EH indicators ........................................................................ 21 3.1 Introduction and background......................................................................................... 21 3.2 Aim and Objectives.........................................................................................................21 3.3 Methods .......................................................................................................................... 22 ii Table of contents Identification of potential indicators................................................................................ 22 Development of methodology ........................................................................................... 23 Definition of the core and extended set of indicators....................................................... 25 3.4 Results and Key findings ................................................................................................ 26 Results from Screening Process ....................................................................................... 26 Core set and extended set of indicators............................................................................ 27 Focus on children............................................................................................................. 27 3.5 Conclusion...................................................................................................................... 34 Constraints and lessons learnt ......................................................................................... 34 Follow-up in ENHIS-2...................................................................................................... 35 Chapter 4 Methods for information generation .................................................................. 36 4.1 Introduction.................................................................................................................... 36 4.2 Aim and objectives..........................................................................................................36
Load more

Recommended publications
  • Safety Data Sheets (Sdss) Information and Glossary
    Safety Data Sheets (SDSs) Information and Glossary 2408 Wanda Daley Drive Ames, Iowa 50011 (515) 294-5359 | www.ehs.iastate.edu Copyright© Reviewed 2018 Safety Data Sheets (SDSs) Information Safety Data Sheets (SDSs) are informational sheets required by the Occupational Safety and Health Administration (OSHA) for hazardous substances (chemicals). The OSHA Hazard Communication Standard (29 CFR 1910.1200) and the Iowa Hazardous Chemical Risks Right to Know Standard (Iowa Administrative Code Section 875, Chapters 110-140) requires SDSs be “readily accessible” for any hazardous chemical in the workplace. Employees must be made aware of the SDS content and chemical storage location. SDSs can be obtained from manufacturers and distributors at the time of initial shipment. Each university workplace must maintain an SDS for each hazardous chemical in its inventory. SDSs that are available electronically meet the “readily accessible” criteria, as long as computer access is available to all employees whenever work is being conducted. EH&S suggests that each workspace also maintain paper copies of commonly used hazardous chemicals for ease of access. OSHA requires specific information be included on an SDS, in a 16-section format as described in the UN Globally Harmonized System of Classification and Labeling of Chemicals (GHS). The SDS must be in English and must include at least the following information: Section 1: Identification includes product identifier; manufacturer or distributor name, address, phone number; emergency phone number; recommended use; restrictions on use. Section 2: Hazard(s) Identification includes all hazards regarding the chemical; required label elements. Section 3: Composition/Information on Ingredients includes information on chemical ingredients; trade secret claims.
    [Show full text]
  • Water Quality, Health, and Place
    November 2015 Water Quality, Health, and Place A RESEARCH BRIEF VERSION 1.1 Photo by Ann Forsyth Photo by The HEALTH AND PLACE INITIATIVE (HAPI) investigates how to create healthier cities in the future, with a specific emphasis on China. Bringing together experts from the Harvard Graduate School of Design (HGSD) and the Harvard School of Public Health (HSPH), it creates a forum for understanding the multiple issues that face cities in light of rapid urbanization and an aging population worldwide. Health and Places Initiative http://research.gsd.harvard.edu/hapi/ Harvard Graduate School of Design The Research Briefs series summarizes recent research on links between human health and places at the neighborhood or district scale and provides background for a number of other forthcoming products—a set of health assessment tools, planning and urban design guidelines, urban design prototypes, and neighborhood cases. While the Research Briefs draw out implications for practice, it is these other tools that really provide specific, real-world guidance for how to create healthy places. © 2015 President and Fellows of Harvard College As is typical practice feel free to use and cite small parts of this work, with attribution. If you want to use substantial parts, or even this entire document, the following applies. Permission is granted for use for nonprofit education purposes for all of the work except third party materials incorporated in the work, which may require permission from the authors of such material. For permission to use this work in other circumstances, contact the Harvard Graduate School of Design: [email protected].
    [Show full text]
  • Nidogen-1 Expression Is Associated with Overall Survival and Temozolomide Sensitivity in Low-Grade Glioma Patients
    www.aging-us.com AGING 2021, Vol. 13, No. 6 Research Paper Nidogen-1 expression is associated with overall survival and temozolomide sensitivity in low-grade glioma patients Baiwei Zhang1,*, Cheng Xu2,3,*, Junfeng Liu1, Jinsheng Yang4, Qinglei Gao2,3, Fei Ye1 1Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China 2Cancer Biology Research Center, Key Laboratory of the Ministry of Education, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China 3Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China 4Department of Neurosurgery, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, China *Equal contribution Correspondence to: Fei Ye; email: [email protected] Keywords: NID1, glioma, basement membrane, apoptosis, temozolomide Received: August 8, 2020 Accepted: February 16, 2021 Published: March 18, 2021 Copyright: © 2021 Zhang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT We investigated the prognostic significance of nidogen-1 (NID1) in glioma. Oncomine, GEPIA, UALCAN, CCGA database analyses showed that NID1 transcript levels were significantly upregulated in multiple cancer types, including gliomas. Quantitative RT-PCR analyses confirmed that NID1 expression was significantly upregulated in glioma tissues compared to paired adjacent normal brain tissue samples (n=9). NID1 silencing enhanced in vitro apoptosis and the temozolomide sensitivity of U251 and U87-MG glioma cells.
    [Show full text]
  • Page 1 the Public Health Benefits of Sanitation Interventions
    The Public Health Benefits of Sanitation Interventions EPAR Brief No. 104 Jacob Lipson, Professor Leigh Anderson & Professor Susan Bolton Prepared for the Water & Sanitation Team of the Bill & Melinda Gates Foundation Evans School Policy Analysis and Research (EPAR) Professor Leigh Anderson, PI and Lead Faculty Associate Professor Mary Kay Gugerty, Lead Faculty December 10, 2010 Introduction Limited sanitation infrastructure, poor hygienic practices, and unsafe drinking water negatively affect the health of millions of people in the developing world. Using sanitation interventions to interrupt disease pathways can significantly improve public health.1 Sanitation interventions primarily benefit public health by reducing the prevalence of enteric pathogenic illnesses, which cause diarrhea. Health benefits are realized and accrue to the direct recipients of sanitation interventions and also to their neighbors and others in their communities. In a report to the United Nations Development Programme (UNDP), Hutton et al. (2006) estimate that the cost- benefit ratio of sanitation interventions in all developing countries worldwide is 11.2.2 This literature review summarizes the risks of inadequate sanitation to public health and presents the empirical evidence on the public health benefits of complete, intermediate and multiple factor sanitation interventions. The sanitation literature frequently uses inconsistent terminology to describe sanitation infrastructure, technologies and intervention types. Where feasible, we report study results using the original terminology of the authors, while also using consistent terminology to facilitate comparisons across studies. In this review and in much of the literature, sanitation interventions are defined as improvements which provide public or household fecal disposal facilities, and/or improve community fecal disposal and treatment methods.3,4 Sanitation interventions are distinct from water interventions, which focus on increasing access to clean water or improving water quality at drinking water sources or points of use.
    [Show full text]
  • Rare Cancers Are Not So Rare: the Rare Cancer Burden in Europe
    EUROPEANJOURNALOFCANCER47 (2011) 2493– 2511 Available at www.sciencedirect.com journal homepage: www.ejconline.com Rare cancers are not so rare: The rare cancer burden in Europe Gemma Gatta a,*, Jan Maarten van der Zwan b, Paolo G. Casali c, Sabine Siesling b, Angelo Paolo Dei Tos d, Ian Kunkler e, Rene´e Otter b, Lisa Licitra f, Sandra Mallone g, Andrea Tavilla g, Annalisa Trama a, Riccardo Capocaccia g, The RARECARE working group a Department of Preventive and Predictive Medicine, Fondazione IRCSS, Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy b North East Netherlands Cancer Registry, Comprehensive Cancer Centre North East, P.O. Box 330, 9700 AH Groningen, The Netherlands c Department of Cancer Medicine, Fondazione IRCSS, Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy d Department of Pathology, General Hospital of Treviso, Via Borgo Cavalli 42, 31100 Treviso, Italy e Department of Clinical Oncology, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK f Head and Neck Cancer Medical Oncology Unit, Fondazione IRCSS, Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy g Department of Cancer Epidemiology, Istituto Superiore di Sanita` , Viale Regina Elena 299, Rome, Italy ARTICLE INFO ABSTRACT Keywords: Purpose: Epidemiologic information on rare cancers is scarce. The project Surveillance of Rare cancers Rare Cancers in Europe (RARECARE) provides estimates of the incidence, prevalence and Cancer registries survival of rare cancers in Europe based on a new and comprehensive list of these diseases. Incidence Materials and methods: RARECARE analysed population-based cancer registry (CR) data on Prevalence European patients diagnosed from 1988 to 2002, with vital status information available Survival up to 31st December 2003 (latest date for which most CRs had verified data).
    [Show full text]
  • Hamdan Medical Journal 2012; 5:79–82
    Hamdan Medical Journal 2012; 5:79–82 LETTER TO THE EDITOR Cancers in Arab populations: concise notes http://dx.doi.org/10.2174/HMJ201201 Sir, social customs followed in Arab populations result in delayed patient presentation to the physician. Rapid improvements in the field of health care and dramatic socioeconomic changes resulting in Prostate cancer lies at the other end of the spectrum. modified lifestyles are believed to have contributed The incidence of clinical prostate cancer in Arabs to the increased incidence of cancers in Arab is among the lowest in the world. This is despite populations.1 For example, the UAE is experiencing a the increased prevalence of risk factors, including continually increasing proportion of cancer burden, the intake of high-caloric food rich in animal fat.7 imposing itself as the third leading cause of death Interestingly, mean serum prostate-specific antigen after cardiovascular diseases and accidents.2 Very (PSA) levels are also known to be low in Arab men. preliminary data from the CTGA (Catalogue for In fact, several studies have pointed towards the Transmission Genetics in Arabs) database for genetic necessity of establishing Arab-specific serum PSA disorders in Arab populations indicate the presence reference levels for early diagnosis of prostate cancer.8 of at least 55 cancer types in Arab people (Table 1). Although these types of cancers vary with regard to Despite the fact that heredity plays little part in their incidence and frequency, strong indicators show the aetiology of most cancer types, studies of clearly that cancers of the lung and prostate are the the molecular genetics of cancers are becoming most common among males whereas breast and invaluable tools to provide insights into the thyroid cancers are the most common among females pathways leading to individual tumours and to in the region (reviewed in reference 4).
    [Show full text]
  • Text-Mining Clinically Relevant Cancer Biomarkers for Curation Into the Civic Database
    bioRxiv preprint doi: https://doi.org/10.1101/500686; this version posted December 20, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Text-mining clinically relevant cancer biomarkers for curation into the CIViC database Jake Lever1,2, Martin R. Jones1, Arpad M. Danos3, Kilannin Krysiak3,5, Melika Bonakdar1, Jasleen Grewal1,2, Luka Culibrk1,2, Obi L. Griffith3,4,5,6,*, Malachi Griffith3,4,5,6,*, and Steven J.M. Jones1,2,7,* 1Canada’s Michael Smith Genome Sciences Centre, Vancouver, BC, Canada. 2University of British Columbia, Vancouver, BC, Canada. 3McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, USA. 4Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA. 5Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA. 6Department of Genetics, Washington University School of Medicine, St. Louis, MO, USA. 7Simon Fraser University, Burnaby, BC, Canada. * co-corresponding author Abstract Precision oncology involves analysis of individual cancer samples to understand the genes and pathways involved in the development and progression of a cancer. To improve patient care, knowledge of diagnostic, prognostic, predisposing and drug response markers is essential. Several knowledgebases have been created by different groups to collate evidence for these associations. These include the open-access Clinical Interpretation of Variants in Cancer (CIViC) knowledgebase. These databases rely on time-consuming manual curation from skilled experts who read and interpret the relevant biomedical literature.
    [Show full text]
  • Role of IQGAP1 in Carcinogenesis
    cancers Review Role of IQGAP1 in Carcinogenesis Tao Wei and Paul F. Lambert * McArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705, USA; [email protected] * Correspondence: [email protected] Simple Summary: IQ motif-containing GTPase-activating protein 1 (IQGAP1) is a signal scaffolding protein that regulates a range of cellular activities by facilitating signal transduction in cells. IQGAP1 is involved in many cancer-related activities, such as proliferation, apoptosis, migration, invasion and metastases. In this article, we review the different pathways regulated by IQGAP1 during cancer development, and the role of IQGAP1 in different types of cancer, including cancers of the head and neck, breast, pancreas, liver, colorectal, stomach, and ovary. We also discuss IQGAP10s regulation of the immune system, which is of importance to cancer progression. This review highlights the significant roles of IQGAP1 in cancer and provides a rationale for pursuing IQGAP1 as a drug target for developing novel cancer therapies. Abstract: Scaffolding proteins can play important roles in cell signaling transduction. IQ motif- containing GTPase-activating protein 1 (IQGAP1) influences many cellular activities by scaffolding multiple key signaling pathways, including ones involved in carcinogenesis. Two decades of studies provide evidence that IQGAP1 plays an essential role in promoting cancer development. IQGAP1 is overexpressed in many types of cancer, and its overexpression in cancer is associated with lower survival of the cancer patient. Here, we provide a comprehensive review of the literature regarding the oncogenic roles of IQGAP1. We start by describing the major cancer-related signaling pathways Citation: Wei, T.; Lambert, P.F.
    [Show full text]
  • Mortality–Air Pollution Associations in Low-Exposure Environments (MAPLE): Phase 1
    RESEARCH REPORT HEA L TH HEA L TH Mortality–Air Pollution Associations EFFE CTS EFFE CTS in Low-Exposure Environments INSTITUTE INSTITUTE (MAPLE): Phase 1 75 Federal Street, Suite 1400 Number 203 Michael Brauer, Jeffrey R. Brook, Tanya Christidis, Boston, MA 02110, USA November 2019 Yen Chu, Dan L. Crouse, Anders Erickson, Perry Hystad, +1-617-488-2300 www.healtheffects.org Chi Li, Randall V. Martin, Jun Meng, Amanda J. Pappin, Lauren L. Pinault, Michael Tjepkema, Aaron van Donkelaar, Scott Weichenthal, and Richard T. Burnett RESEARCH REPORT Number 203 November 2019 Includes a Commentary by HEI’s Low-Exposure Epidemiology Studies Review Panel ISSN 1041-5505 (print) ISSN 2688-6855 (online) Mortality–Air Pollution Associations in Low-Exposure Environments (MAPLE): Phase 1 Michael Brauer, Jeffrey R. Brook, Tanya Christidis, Yen Chu, Dan L. Crouse, Anders Erickson, Perry Hystad, Chi Li, Randall V. Martin, Jun Meng, Amanda J. Pappin, Lauren L. Pinault, Michael Tjepkema, Aaron van Donkelaar, Scott Weichenthal, and Richard T. Burnett with a Commentary by HEI’s Low-Exposure Epidemiology Studies Review Panel Research Report 203 Health Effects Institute Boston, Massachusetts Trusted Science · Cleaner Air · Better Health Publishing history: This document was posted at www.healtheffects.org in November 2019. Citation for document: Brauer M, Brook JR, Christidis T, Chu Y, Crouse DL, Erickson A, et al. 2019. Mortality–Air Pollution Associations in Low-Exposure Environments (MAPLE): Phase 1. Research Report 203. Boston, MA:Health Effects Institute. © 2019 Health Effects Institute, Boston, Mass., U.S.A. Cameographics, Belfast, Me., Compositor. Printed by Recycled Paper Printing, Boston, Mass. Library of Congress Catalog Number for the HEI Report Series: WA 754 R432.
    [Show full text]
  • 4. What Are the Effects of Education on Health? – 171
    4. WHAT ARE THE EFFECTS OF EDUCATION ON HEALTH? – 171 4. What are the effects of education on health? By Leon Feinstein, Ricardo Sabates, Tashweka M. Anderson, ∗ Annik Sorhaindo and Cathie Hammond ∗ Leon Feinstein, Ricardo Sabates, Tashweka Anderson, Annik Sorhaindo and Cathie Hammond, Institute of Education, University of London, 20 Bedford Way, London WC1H 0AL, United Kingdom. We would like to thank David Hay, Wim Groot, Henriette Massen van den Brink and Laura Salganik for the useful comments on the paper and to all participants at the Social Outcome of Learning Project Symposium organised by the OECD’s Centre for Educational Research and Innovation (CERI), in Copenhagen on 23rd and 24th March 2006. We would like to thank the OECD/CERI, for their financial support of this project. A great many judicious and helpful suggestions to improve this report have been put forward by Tom Schuller and Richard Desjardins. We are particularly grateful for the general funding of the WBL Centre through the Department for Education and Skills whose support has been a vital component of this research endeavour. We would also like to thank research staff at the Centre for Research on the Wider Benefits of Learning for their useful comments on this report. Other useful suggestions were received from participants at the roundtable event organised by the Wider Benefits of Learning and the MRC National Survey of Health and Development, University College London, on 6th December 2005. All remaining errors are our own. MEASURING THE EFFECTS OF EDUCATION ON HEALTH AND CIVIC ENGAGEMENT: PROCEEDINGS OF THE COPENHAGEN SYMPOSIUM – © OECD 2006 172 – 4.1.
    [Show full text]
  • Every Breath We Take: the Lifelong Impact of Air Pollution
    Every breath we take: the lifelong impact of air pollution Report of a working party February 2016 The Royal College of Physicians The Royal College of Physicians (RCP) plays a leading role in the delivery of high-quality patient care by setting standards of medical practice and promoting clinical excellence. The RCP provides physicians in over 30 medical specialties with education, training and support throughout their careers. As an independent charity representing 32,000 fellows and members worldwide, the RCP advises and works with government, patients, allied healthcare professionals and the public to improve health and healthcare. Citation for this document : Royal College of Physicians. Every breath we take: the lifelong impact of air pollution . Report of a working party. London: RCP, 2016. Copyright All rights reserved. No part of this publication may be reproduced in any form (including photocopying or storing it in any medium by electronic means and whether or not transiently or incidentally to some other use of this publication) without the written permission of the copyright owner. Applications for the copyright owner’s written permission to reproduce any part of this publication should be addressed to the publisher. Copyright © Royal College of Physicians 2016 ISBN 978-1-86016-567-2 eISBN 978-1-86016-568-9 Royal College of Physicians 11 St Andrews Place Regent’s Park London NW1 4LE www.rcplondon.ac.uk Registered charity no 210508 Typeset by Cambrian Typesetters, Camberley, Surrey Printed and bound in Great Britain by The Lavenham
    [Show full text]
  • WO 2009/080437 Al
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date (10) International Publication Number 2 July 2009 (02.07.2009) PCT WO 2009/080437 Al (51) International Patent Classification: Copenhagen N (DK). LITMAN, Thomas [DK/DK]; C12Q 1/68 (2006.01) Rosen AlIe 8, Hareskovby, DK-3500 Vaeløse (DK). M0LLER, Søren [DK/DK]; Ved Furesøen 9, DK-2840 (21) International Application Number: Holte (DK). PCT/EP2008/066239 (74) Agent: INSPICOS A/S; P.O. Box 45, Kogle AlIe 2, (22) International Filing Date: DK-2970 Hørsholm (DK). 26 November 2008 (26.1 1.2008) (81) Designated States (unless otherwise indicated, for every (25) Filing Language: English kind of national protection available): AE, AG, AL, AM, (26) Publication Language: English AO, AT,AU, AZ, BA, BB, BG, BH, BR, BW, BY,BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, (30) Priority Data: EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, PA 2007 01843 2 1 December 2007 (21.12.2007) DK IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, 61/015,797 21 December 2007 (21.12.2007) US LR, LS, LT, LU, LY,MA, MD, ME, MG, MK, MN, MW, PA 2008 00535 11 April 2008 (11.04.2008) DK MX, MY,MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, (71) Applicant (for all designated States except US): EXIQON RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY,TJ, A/S [DK/DK]; Skelstedet 16, DK-2950 VEDB^K (DK).
    [Show full text]